Literature DB >> 28511289

Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis.

Richard J Cuthbert1, Evangelos M Fragkakis2, Robert Dunsmuir3, Zhi Li4, Mark Coles4, Helena Marzo-Ortega5, Peter V Giannoudis1, Elena Jones1, Yasser M El-Sherbiny6, Dennis McGonagle5.   

Abstract

OBJECTIVE: Group 3 innate lymphoid cells (ILC3s) play a pivotal role in barrier tissues such as the gut and the skin, two important sites of disease in spondyloarthritis (SpA). This study was undertaken to investigate whether normal or injured human enthesis, a key target tissue in early SpA, harbors ILC3s in entheseal soft tissue and adjacent perientheseal bone.
METHODS: Interspinous ligament and spinous process bone from donors with no systemic inflammatory disease were collected, enzymatically digested, and immunophenotyped. The immunologic profile of entheseal cells was examined, and the transcriptional profile of sorted ILC3s was compared to that of ILC3s isolated from SpA synovial fluid (SF). To assess the ability of entheseal tissue to produce interleukin-17 (IL-17) and IL-22, entheseal digests were stimulated with IL-23 and IL-1β. Osteoarthritic and ruptured Achilles tendon tissue was examined histologically.
RESULTS: The proportion of ILCs in human entheseal soft tissue was higher than that in peripheral blood (P = 0.008); entheseal soft tissue and perientheseal bone both had a higher proportion of NKp44+ ILC3s (P = 0.001 and P = 0.043, respectively). Studies of retinoic acid receptor-related orphan nuclear receptor γt (RORγt), STAT3, and IL-23 receptor transcript expression validated the entheseal ILC3 phenotype. Cytokine transcript expression was similar in ILC3s isolated from enthesis and from SpA SF. Stimulation of normal entheseal digests with IL-23/IL-1β led to up-regulation of IL-17A transcript, and histologic examination of injured/damaged entheses revealed the presence of RORγt-expressing cells.
CONCLUSION: This work shows that human enthesis harbors a resident population of ILC3s, with the potential to participate in the pathogenesis of SpA.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28511289     DOI: 10.1002/art.40150

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  52 in total

Review 1.  [Novel molecular mechanisms in the pathophysiology of psoriatic arthritis].

Authors:  D Simon; E Kampylafka; A J Hueber
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

Review 2.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 3.  New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Authors:  Sayam Dubash; Dennis McGonagle; Helena Marzo-Ortega
Journal:  Ther Adv Chronic Dis       Date:  2017-12-14       Impact factor: 5.091

Review 4.  Enthesitis: from pathophysiology to treatment.

Authors:  Georg Schett; Rik J Lories; Maria-Antonietta D'Agostino; Dirk Elewaut; Bruce Kirkham; Enrique R Soriano; Dennis McGonagle
Journal:  Nat Rev Rheumatol       Date:  2017-11-21       Impact factor: 20.543

Review 5.  ILC3 in Axial Spondyloarthritis: the Gut Angle.

Authors:  Daniele Mauro; Federica Macaluso; Serena Fasano; Riccardo Alessandro; Francesco Ciccia
Journal:  Curr Rheumatol Rep       Date:  2019-06-13       Impact factor: 4.592

6.  Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.

Authors:  Lu Yang; Melania H Fanok; Aranzazu Mediero-Munoz; Laura K Fogli; Carmen Corciulo; Shahla Abdollahi; Bruce N Cronstein; Jose U Scher; Sergei B Koralov
Journal:  Arthritis Rheumatol       Date:  2018-04-18       Impact factor: 10.995

7.  Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments.

Authors:  Gurjit S Kaeley; Jaspreet K Kaler
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

8.  HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis.

Authors:  Chin-Hsiu Liu; Sengupta Raj; Chun-Hsiung Chen; Kuo-Hsuan Hung; Chung-Tei Chou; Ing-Ho Chen; Jui-Teng Chien; I-Ying Lin; Shii-Yi Yang; Takashi Angata; Wen-Chan Tsai; James Cheng-Chung Wei; I-Shiang Tzeng; Shih-Chieh Hung; Kuo-I Lin
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 9.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 10.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.